Catalyst
A recent MACD Death Cross on January 28 signals a bullish bias for EMR.
Risk
All four active analysts rate EMR as Neutral, indicating a lack of strong institutional optimism.
Fund flows show negative trends across all order sizes, suggesting declining investor interest.
Generated at20:1801/31/2026by
Aime
